E7080 in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma
| Status: | Archived |
|---|---|
| Conditions: | Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2010 |
| End Date: | August 2012 |
An Open-Label, Multicenter, Randomized, Phase Ib/II Study of E7080 in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma.
Primary:
- Phase Ib: To define the safety, tolerability and maximum tolerated dose (MTD) of E7080
administered in combination with dacarbazine.
- Phase II: To evaluate the safety and tolerability of E7080 administered in combination
with dacarbazine, compared with dacarbazine alone.
Secondary:
• Phase II: to make a preliminary assessment of the efficacy of E7080 administered in
combination with dacarbazine, compared with dacarbazine alone.
We found this trial at
5
sites
Click here to add this to my saved trials
5303 Harry Hines Boulevard
Dallas, Texas 75390
Dallas, Texas 75390
(214) 648-3111
UT Soutwestern Medical Center at Dallas UT Southwestern Medical Center is distinctive for its overall...
Click here to add this to my saved trials
900 West Faris Road
Greenville, South Carolina 29605
Greenville, South Carolina 29605
(864) 679-3900
Cancer Centers of the Carolinas - Faris Road Cancer Centers of the Carolinas is now...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials